Clinical trial
Surfactant Therapy Via Supraglottic Airway Device Versus Endotracheal Intubation to Prevent Mechanical Ventilation in Preterm Neonates With Respiratory Distress Syndrome: An Open-label, Non-inferiority, Randomized Controlled Trial at a Level-III Neonatal Intensive Care Unit in Vietnam
NCT07098910 is registered in ClinicalTrials.gov with Karolinska Institutet as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Surfactant Therapy Via Supraglottic Airway Device Versus Endotracheal Intubation to Prevent Mechanical Ventilation in Preterm Neonates With Respiratory Distress Syndrome: An Open-label, Non-inferiority, Randomized Controlled Trial at a Level-III Neonatal Intensive Care Unit in Vietnam
- Lead sponsor
- Karolinska Institutet
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- September 28, 2025
- Completion date
- March 30, 2029
- Enrollment
- 440 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
respiratory distress syndrome in premature infant